Recent clinical studies have focused on anxiety, bipolar disorder, depression, eating disorders, post-traumatic stress disorder, schizophrenia, addiction, obsessive-compulsive disorder, and late-life depression, among others. Learn what clinical trials we are currently conducting:

The Department of Psychiatry at NYU Langone is a world leader in research, with a long-standing mission of improving the mental health and wellbeing of adult patients experiencing a wide range of psychiatric illnesses.

Research in our department covers a wealth of subjects ranging from basic neurobiology to clinical, epidemiological, child psychiatry and services-related studies. Our facility has been the site of many of the major discoveries in psychiatry.

Learn about research at Icahn Mount Sinai's Department of Psychiatry, advancing the prevention, treatment, and cure of mental illnesses across the board.

The Department of Psychiatry possesses a portfolio of research studies, projects, and training programs that spans a wide array of focus areas in basic, translational & clinical psychiatric research.

Our research encompasses understanding psychiatric disorders through studies in neurogenetics and neurochemistry; brain imaging; evaluating cognition deficits; understanding the molecular and cellular basis of diseases; and early intervention for people at high risk.

We're leading the nation in advanced research and care for schizophrenia, suicidal depression, addiction and first-episode psychosis. The Institute of Behavioral Science focuses on mental disorders and is internationally recognized for its research in schizophrenia.

OMH is a leader in psychiatric research, innovation, and education. We continue to break new ground in the worlds of practice and treatment. Our research guides front line policies and programs to better serve all New Yorkers.